Akiko Saito

Akiko Saito

Auto-generated profile, based on publicly available information

Akiko Saito

Gastroenterology and Hepatology, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya-ku, Tokyo, 150-8935, Japan.

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2011 in Cancer Science
Verified
Journal Article
Open access
PDF file
RFRyohei Furumai
Ryohei Furumai
AIAkihiro Ito
Akihiro Ito
KOKenji Ogawa
Kenji Ogawa
SMSatoko Maeda
Satoko Maeda
ASAkiko Saito
Akiko Saito
MYMinoru Yoshida
Minoru Yoshida
Histone deacetylase inhibitors (HDACi) have been shown to exhibit anti‐inflammatory activity, but their mechanism of action is poorly understood. Trichostatin A (TSA) and the cyclic tetrapeptide class inhibitor Ky‐2 inhibit both lipopolysaccharide‐induced tumor necrosis factor‐α (TNF‐α) production in rats and TNF‐α‐induced expression of inflammatory genes in HeLa cells. We assessed the molecular mechanism underlying TSA‐induced anti‐inflammatory activity by genetically dissecting activation of the nuclear factor‐κB (NF‐κB) pathway following stimulation with TNF‐α. Trichostatin A did not inhibit degradation of IκBα, nuclear translocation and DNA binding of NF‐κB; also, the drug did not affect transient expression from exogenous κB‐reporter plasmids. However, endogenous expression of inflammatory cytokines such as interleukin‐8 (IL‐8) was greatly reduced, even in the absence of de novo protein synthesis, suggesting that HDACi directly inhibits NF‐κB‐induced transcription. Indeed, chromatin immunoprecipitation (ChIP) analysis showed that events related to transcriptional activation of the IL‐8 gene region in response to TNF‐α, including recruitment of RNA polymerase II (Pol II), were compromised in the presence of TSA. These data indicate that HDAC activity is required for the efficient initiation and/or elongation of inflammatory gene transcription mediated by NF‐κB. (Cancer Sci 2011; 102: 1081–1087)

21 August 2017 in Journal of Medical Ultrasonics
Verified
Journal Article
Closed access
PDF file
KMKazumoto Murata
Kazumoto Murata
ASAkiko Saito
Akiko Saito
SKSatoshi Katagiri
Satoshi Katagiri
SAShunichi Ariizumi
Shunichi Ariizumi
MNMasayuki Nakano
Masayuki Nakano
MYMasakazu Yamamoto
Masakazu Yamamoto

1 November 2012
Verified
Journal Article
Closed access
JTJun Takasaki
Jun Takasaki
KAKuniyoshi Arai
Kuniyoshi Arai
MAMasayuki Ando
Masayuki Ando
TNTakeshi Nagahama
Takeshi Nagahama
AFAkira Fukuda
Akira Fukuda
ASAkiko Saito
Akiko Saito

26 March 2024 in Clinical Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
RURen Ueta
Ren Ueta
ASAkiko Saito
Akiko Saito
YYYuka Yanai
Yuka Yanai
YOYuki Otake
Yuki Otake
CYChizu Yokoi
Chizu Yokoi
TTTsuyoshi Tajima
Tsuyoshi Tajima

1 January 1992 in Kanzo
Verified
Journal Article
Open access
PDF file
MTMakiko Taniai
Makiko Taniai
MTMasahiko Tomimatsu
Masahiko Tomimatsu
NINoriko Ishiguro
Noriko Ishiguro
KYKingo Yoshida
Kingo Yoshida
EHEtsuko Hashimoto
Etsuko Hashimoto
MNMasayuki Nakano
Masayuki Nakano
症例は59歳男性.職業は溶接業.トロトラスト,塩化ビニールモノマー(VCM),素などの直接の汚染歴なし.昭和56年より肝障害と食道静脈瘤を指摘され,昭和59年,腹部超音波検査にて,肝内に占拠性病変を認めた為,精査目的で入院.入院時,肝脾腫,及び食道,胃静脈瘤,血小板減少を認め,各種画像診断上,肝には左葉内側区域と右葉にそれぞれ約7×10cm, 5×7cm程度の塊状の腫瘍が認められた.入院3ヵ月後に肝不全,呼吸不全にて死亡.剖検所見では,腫瘍は肉眼的には血管腫様で,総織学的には紡錘形の腫瘍細胞の充実性増生と,部分的には血管腫様の管腔形成を認め,肝血管肉鍾と診断.他臓器(肺及び骨髄)の転移巣も同様の所見であった.また,非腫瘍部の一部には,Edmondson III型の肝細胞癌も顕微鏡的に観察された.非腫瘍部には肝硬変はなく,門脈枝の硬化,異常血行路を認め,特発性門脈圧亢進症(IPH)に類似した組織像であった.

3 April 2018 in Journal of Medical Ultrasonics
Verified
Journal Article
Closed access
PDF file
VSVasanthapriya Subramaniyam
Vasanthapriya Subramaniyam
ASAkiko Saito
Akiko Saito
KTKatsutoshi Tokushige
Katsutoshi Tokushige